You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (13)

Journals (0)

1-10 of 13 results for advanced HER2-negative gastric cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Cost-effectiveness analysis of Cadonilimab in first-line treatment of advanced HER2-negative gastric cancer or gastroesophageal junction cancer

Open access

Research article

First published 2025

Cost-effectiveness analysis of Cadonilimab in first-line treatment of advanced HER2-negative gastric cancer or gastroesophageal junction cancer

Kaiqi Zhu, Mengyao Qin, Zhaoyi Pan [...]

Therapeutic Advances in Gastroenterology

Select article: Efficacy and Safety of mDCF as First-Line Therapy for HER2-Negative Advanced Gastric Cancer in Vietnam: A Real-World Retrospective Study

Open access

Research article

First published 2025-08

Efficacy and Safety of mDCF as First-Line Therapy for HER2-Negative Advanced Gastric Cancer in Vietnam: A Real-World Retrospective Study

Thi Yen Le, Lan Anh Thi Dinh, Van Thi Nguyen [...]

Cancer Control

Select article: Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

Open access

Research article

First published 2025

Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

Keitaro Shimozaki, Akira Ooki, Koichiro Yoshino [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness analysis of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy for advanced HER2-negative gastric or gastro-esophageal junction cancer

Open access

Research article

First published 2025

Cost-effectiveness analysis of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy for advanced HER2-negative gastric or gastro-esophageal junction cancer

Yitian Lang, Weican Cao, Yan Lin [...]

Therapeutic Advances in Gastroenterology

Select article: Immune checkpoint inhibitors plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer: a cost-effectiveness analysis

Open access

Research article

First published 2023

Immune checkpoint inhibitors plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer: a cost-effectiveness analysis

Youwen Zhu, Kun Liu, Hong Zhu [...]

Therapeutic Advances in Gastroenterology

Select article: HER2 becomes a novel survival biomarker for gastric cancer patients: a pooled analysis

Open access

Research article

First published 2024

HER2 becomes a novel survival biomarker for gastric cancer patients: a pooled analysis

Ji Cheng, Ming Cai, Guobin Wang [...]

Therapeutic Advances in Medical Oncology

Select article: The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Free access

Research article

First published 2016-2

The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Jianjun Qu, Xiangyang Qu

Cancer Biomarkers

Select article: α-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation

Retricted access

Case report

First published 2015-10

α-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation

Andrzej Wincewicz, Artur Kowalik, Sebastian Zięba [...]

International Journal of Surgical Pathology

Select article: Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis

Open access

Research article

First published 2026

Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis

Jia Wang, Baolong Ding, Zhuying Jing [...]

Therapeutic Advances in Medical Oncology

Select article: The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study

Open access

Research article

First published 2022

The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study

Xiaofang Zhang, Weigang Wang, Baoguo Tian [...]

Clinical Medicine Insights: Oncology

1
2
10 / page

Article type

Publication date

Subjects

Access